<header id=038353>
Published Date: 2022-12-17 13:49:58 EST
Subject: PRO/ALL> New in IJID (12): December 2022
Archive Number: 20221217.8707323
</header>
<body id=038353>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (12): DECEMBER 2022
***********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: December 2022
Source: IJID [edited]
https://www.ijidonline.com/


Coronavirus (COVID-19) full-length articles
-------------------------------------------
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of delta and omicron variant predominance in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
Mimura et al.
Int J Infect Dis. 2022;125:58-60
https://doi.org/10.1016/j.ijid.2022.10.001

Effect of corticosteroids in patients with COVID-19: A Bayesian network meta-analysis
Wang et al.
Int J Infect Dis. 2022;125:84-92
https://doi.org/10.1016/j.ijid.2022.10.021

Testing for COVID-19 during an outbreak within a large UK prison: An evaluation of mass testing to inform outbreak control
Blackmore et al.
Int J Infect Dis. 2022;125:138-144
https://doi.org/10.1016/j.ijid.2022.10.018

Clinical outcomes associated with mu variant infection during the third epidemic peak of COVID-19 in Colombia
Álvarez-Día et al.
Int J Infect Dis. 2022;125:149-152
https://doi.org/10.1016/j.ijid.2022.10.028

High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: An observational study of comparative effectiveness
Langer-Gould et al.
Int J Infect Dis. 2022;125:184-191
https://doi.org/10.1016/j.ijid.2022.10.023

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Farroni et al.
Int J Infect Dis. 2022;125:195-208
https://doi.org/10.1016/j.ijid.2022.10.035

SARS-CoV-2 genomic surveillance in Malaysia: Displacement of B.1.617.2 with AY lineages as dominant delta variants and the introduction of omicron during the fourth epidemic wave
Muhammad Azami et al.
Int J Infect Dis. 2022;125:216-226
https://doi.org/10.1016/j.ijid.2022.10.044

Baricitinib vs tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study
Lakatos et al.
Int J Infect Dis. 2022;125:233-240
https://doi.org/10.1016/j.ijid.2022.10.037

High prevalence of SARS-CoV-2 antibodies in pregnant women, after the second wave of infections in the inner city of Johannesburg, Gauteng Province, South Africa
Sawry et al.
Int J Infect Dis. 2022;125:241-249
https://doi.org/10.1016/j.ijid.2022.10.036

Comparative analysis of elderly hospitalized patients with coronavirus disease 2019 or influenza A H1N1 virus infections
Lv et al.
Int J Infect Dis. 2022;125:278-284
https://doi.org/10.1016/j.ijid.2022.11.008

Characteristics of long-COVID among older adults: A cross-sectional study
Daitch et al.
Int J Infect Dis. 2022;125:287-293
https://doi.org/10.1016/j.ijid.2022.09.035

Perspectives
------------
Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19
Visser et al.
Int J Infect Dis. 2022;125:275-277
https://doi.org/10.1016/j.ijid.2022.10.030

Reviews
-------
Global trends of pulmonary infections with nontuberculous mycobacteria: A systematic review
Dahl et al.
Int J Infect Dis. 2022;125:120-131
https://doi.org/10.1016/j.ijid.2022.10.013

Original reports
----------------
Fatal patients with severe fever with thrombocytopenia syndrome in China
Zhao et al.
Int J Infect Dis. 2022;125:10-16
https://doi.org/10.1016/j.ijid.2022.10.008

Exploring the eligibility of all reported lipoarabinomannan-testing assays in different clinical situations: A systematic review and meta-analysis of 97 articles
Lyu et al.
Int J Infect Dis. 2022;125:19-34
https://doi.org/10.1016/j.ijid.2022.10.015

Vaccine-associated paralytic poliomyelitis in a child: Fast transformation from Sabin-like virus to vaccine-derived poliovirus triggered an epidemiological response in two countries of the European region
Ivanova et al.
Int J Infect Dis. 2022;125:35-41
https://doi.org/10.1016/j.ijid.2022.09.034

T-SPOT with CT image analysis based on deep learning for early differential diagnosis of nontuberculous mycobacteria pulmonary disease and pulmonary tuberculosis
Ying et al.
Int J Infect Dis. 2022;125:42-50
https://doi.org/10.1016/j.ijid.2022.09.031

Comparison between a rapid diagnostic test and dried blood spot-based immunoassay for hepatitis B surface antigen testing: Performance and cost implications in a population-based serosurvey in Vietnam
Okawa et al.
Int J Infect Dis. 2022;125:51-57
https://doi.org/10.1016/j.ijid.2022.10.011

Toll-like receptor and matrix metalloproteinase single nucleotide polymorphisms, haplotypes and polygenic risk score differentiated between tuberculosis disease and infection
Lee et al.
Int J Infect Dis. 2022;125:61-66
https://doi.org/10.1016/j.ijid.2022.10.020

The relation of body mass index, body height, and parity to pyelonephritis: A nationwide population-based cohort study of over one million parous women (1997-2018)
Jansåke et al.
Int J Infect Dis. 2022;125:67-73
https://doi.org/10.1016/j.ijid.2022.10.022

_Mycobacterium tuberculosis_ genetic features associated with pulmonary tuberculosis severity
Genestet et al.
Int J Infect Dis. 2022;125:74-83
https://doi.org/10.1016/j.ijid.2022.10.026

Clinical features and treatment strategies of febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A multicenter retrospective observational study in Japan
Ohnishi et al.
Int J Infect Dis. 2022;125:97-102
https://doi.org/10.1016/j.ijid.2022.09.033

Prokineticin 2 promotes macrophages-mediated antibacterial host defense against bacterial pneumonia
Tu et al.
Int J Infect Dis. 2022;125:103-113
https://doi.org/10.1016/j.ijid.2022.10.003

A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City
Hernández-Hernández et al.
Int J Infect Dis. 2022;125:114-119
https://doi.org/10.1016/j.ijid.2022.10.029

Global influenza vaccination rates and factors associated with influenza vaccination
Chen et al.
Int J Infect Dis. 2022;125:153-163
https://doi.org/10.1016/j.ijid.2022.10.038

Relative effectiveness of the adjuvanted versus non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults
Domnich et al.
Int J Infect Dis. 2022;125:164-169
https://doi.org/10.1016/j.ijid.2022.10.041

Epidemiological and genomic investigations of an unusual increase in _Salmonella enterica_ serovar Paratyphi A infection among travelers returning from Myanmar in 2015
Matono et al.
Int J Infect Dis. 2022;125:170-176
https://doi.org/10.1016/j.ijid.2022.10.034

High seroprevalence of antibodies against human respiratory syncytial virus and evidence of RSV reinfection in young children in Thailand
Pasittungkul et al.
Int J Infect Dis. 2022;125:177-183
https://doi.org/10.1016/j.ijid.2022.10.039

Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for _Pneumocystis jirovecii_ pneumonia in adult recipients of kidney transplantation: A real-world data study
Chen et al.
Int J Infect Dis. 2022;125:209-215
https://doi.org/10.1016/j.ijid.2022.10.004

Activity of ceftolozane/tazobactam against clinical isolates of _Pseudomonas aeruginosa_ from patients in the Middle East and Africa -- Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020
Lob et al.
Int J Infect Dis. 2022;125:250-257
https://doi.org/10.1016/j.ijid.2022.10.014

Effects of ivermectin mass drug administration for malaria vector control on ectoparasites and soil-transmitted helminths: A cluster randomised trial
Kositz et al.
Int J Infect Dis. 2022;125:258-264
https://doi.org/10.1016/j.ijid.2022.10.043

Hansen's disease (leprosy) in Japan, 1947-2020: An epidemiologic study during the declining phase to elimination
Yotsu et al.
Int J Infect Dis. 2022;125:265-274
https://doi.org/10.1016/j.ijid.2022.10.027

Prevalence and antimicrobial resistance profiles of _Campylobacter_ species in South Africa: A "One Health" approach using systematic review and meta-analysis
Ramatla et al.
Int J Infect Dis. 2022;125:294-304
https://doi.org/10.1016/j.ijid.2022.10.042

Case reports
------------
Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): A case report and literature review
Kubo et al.
Int J Infect Dis. 2022;125:1-9
https://doi.org/10.1016/j.ijid.2022.09.009

SARS-CoV-2 vertical transmission in a twin-pregnant woman: A case report
Sessa et al.
Int J Infect Dis. 2022;125:192-194
https://doi.org/10.1016/j.ijid.2022.10.019

Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: A case report
Brosh-Nissimov et al.
Int J Infect Dis. 2022;125:93-95
https://doi.org/10.1016/j.ijid.2022.09.038

Direct diagnosis of scrub typhus by full-length 16S ribosomal RNA gene analysis using Oxford Nanopore sequencing
Sharda et al.
Int J Infect Dis. 2022;125:132-134
https://doi.org/10.1016/j.ijid.2022.10.040

A severe monkeypox infection in a patient with an advanced HIV infection treated with Tecovirimat: Clinical and virological outcome
Viguier et al.
Int J Infect Dis. 2022;125:135-137
https://doi.org/10.1016/j.ijid.2022.10.031

Purulent lymphadenitis due to _Halomonas hamiltonii_: A case report
Uejima et al.
Int J Infect Dis. 2022;125:145-148
https://doi.org/10.1016/j.ijid.2022.10.032

Breast hydatid cyst presented as a fluctuant painless lump mimicking galactocele: Case report
Assefa et al.
Int J Infect Dis. 2022;125:228-230
https://doi.org/10.1016/j.ijid.2022.11.004

Correspondence
--------------
No evidence of rabbit-derived human _Thelazia callipaeda_ infection: A call for attention to basic biology of this parasite
Bezerra-Santos et al.
Int J Infect Dis. 2022;125:17-18
https://doi.org/10.1016/j.ijid.2022.10.012

Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
Saldivar-Espinoza et al.
Int J Infect Dis. 2022;125:231-232
https://doi.org/10.1016/j.ijid.2022.11.002

Could nucleocapsid be a next-generation COVID-19 vaccine candidate -- Author's reply
Oronsky et al.
Int J Infect Dis. 2022;125:227
https://doi.org/10.1016/j.ijid.2022.11.001

Workup for cerebral involvement in COVID-19 requires cerebral imaging, electroencephalography, and cerebrospinal fluid studies
Finsterer et al.
Int J Infect Dis. 2022;125:285-286
https://doi.org/10.1016/j.ijid.2022.10.025

Corrigendum
------------
Corrigendum to 'Kyasanur Forest Disease, is our surveillance system healthy to prevent a larger outbreak? A mixed-method study, Shivamogga, Karnataka, India: 2019' International Journal of Infectious Diseases, Volume 110S1, October 2021, Pages S50-S61
Bhat et al.
Int J Infect Dis. 2022;125:96
https://doi.org/10.1016/j.ijid.2022.10.017

--
Communicated by:
ProMED

[As 2022 comes to a close, the ISID and ProMED teams wish everyone a safe and happy new year. Be on the lookout for the latest addition to the ISID family of journals, IJID One Health, coming in early 2023. IJID One Health traverses human, animal, and environmental health, covering the domains of diagnoses/diagnostics, surveillance, epidemiology, public health capacities and interventions. - Mod.JH]
See Also
New in IJID (11): November 2022 20221105.8706574
New in IJID (10): October 2022 20221010.8706059
New in IJID (09): September 2022 20221004.8705947
New in IJID (06): June 2022 20220628.8704130
New in IJID (05): May 2022 20220505.8703058
New in IJID (04): April 2022 20220405.8702421
New in IJID (03): March 2022 20220304.8701795
New in IJID (02): February 2022 20220206.8701298
New in IJID (01): December 2021 20220109.8700756
2021
----
New in IJID (11): November 2021 20211205.8700079
New in IJID (10): October 2021 20211107.8699506
New in IJID (09): September 2021 20211007.8698901
New in IJID (08): August 2021 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
and other items in the archives
.................................................jh/rd/mpp
</body>
